UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-QSB

[X]   QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
      OF 1934

                For the Quarterly Period Ended September 30, 1999

                       Commission file number 333-05826-A

[ ]   TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
      OF 1934

         For The Transition Period From ___________ To _______________.

                           ATLANTIC INTEGRATED HEALTH
                                  INCORPORATED
        (Exact name of small business issuer as specified in its charter)

     North Carolina                                        56-1966823
(State of Incorporation)                       (IRS Employer Identification No.)


                        1315 S. Glenburnie Road, Suite A5
                         New Bern, North Carolina 28562
                    (Address of principal executive offices)

                                 (252) 514-0057
                         (Registrant's telephone number)

Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the past 12 months (or for such shorter period that the Registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days.      YES [X]        NO[ ]

Indicate the number of shares outstanding of each of the issuer's classes of
common stock as of the latest practicable date.

                    Class                    Outstanding as of November 10, 1999
                    -----                    -----------------------------------

Primary Class, $1.00 par value                              316,500
Referral Class, $1.00 par value                             456,000
Nonprofit Class, nonvoting, $1.00 par value                   4,500

Transitional Small Business Disclosure Format (check one):    Yes [ ]    No [X]

                                       1
<PAGE>


                         PART I - FINANCIAL INFORMATION

ITEM 1 - FINANCIAL STATEMENTS

                     ATLANTIC INTEGRATED HEALTH INCORPORATED

                           Consolidated Balance Sheets

<TABLE>
<CAPTION>
ASSETS                                                           September 30,  December 31,
                                                                     1999           1998
                                                                   ---------     ---------
                                                                  (Unaudited)      (Note)
<S>                                                                <C>           <C>
Cash ..........................................................    $ 203,096     $ 115,507
Accounts receivable, less allowance for
     uncollectible accounts of $5,000 in 1999 and 1998 ........      128,610        64,934
Prepaid expenses ..............................................        5,053         3,562
                                                                   ---------     ---------
                       Total current assets ...................      336,759       184,003
Office equipment, net .........................................       13,966         6,803
Deferred costs and other intangible assets ....................           --        82,711
                                                                   ---------     ---------
Total assets ..................................................    $ 350,725     $ 273,517
                                                                   =========     =========

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities - Accounts payable ........................    $  59,669     $  45,766
                                                                   ---------     ---------
Long-term debt - Convertible debenture and accrued interest....       96,750        92,700
                                                                   ---------     ---------
Stockholders' equity:
     Common stock - $1 par value-
          Primary class,  authorized  1,000,000 shares; 316,500
              and 302,500 shares issued and outstanding in
              1999 and 1998, respectively .....................      316,500       302,500
          Referral class,  authorized 1,800,000 shares; 456,000
              and 370,000 shares issued and outstanding in
              1999 and 1998, respectively .....................      456,000       370,000
          Nonprofit class,  nonvoting,  authorized 200,000
              shares;  4,500 and 2,500 shares issued and
              outstanding in 1999 and 1998, respectively ......        4,500         2,500
     Additional paid-in capital ...............................       74,000        74,000
     Syndication costs ........................................     (110,000)     (105,000)
     Stock subscription and stockholder notes receivable ......      (15,550)      (36,100)
     Accumulated deficit ......................................     (531,144)     (472,849)
                                                                   ---------     ---------
Total stockholders' equity ....................................      194,306       135,051
                                                                   ---------     ---------
Total liabilities and stockholders' equity ....................    $ 350,725     $ 273,517
                                                                   =========     =========
</TABLE>



Note:       The balance sheet as of December 31, 1998 has been derived from the
            audited financial statements at that date but does not include all
            of the information and footnotes required by generally accepted
            accounting principles.

          See accompanying notes to consolidated financial statements.

                                       2
<PAGE>


                     ATLANTIC INTEGRATED HEALTH INCORPORATED

                      Consolidated Statements of Operations
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                                                Three Months Ended           Nine Months Ended
                                                                                   September 30,               September 30,
                                                                              -----------------------     -----------------------
                                                                                1999          1998          1999          1998
                                                                              ---------     ---------     ---------     ---------
<S>                                                                           <C>           <C>           <C>           <C>
Revenue ..................................................................    $ 134,801     $  55,665     $ 400,141     $ 199,135
                                                                              ---------     ---------     ---------     ---------
Expenses:
     Consulting fees .....................................................        1,946        16,488        21,420        23,885
     Salaries and wages ..................................................      108,110        57,160       267,036       214,733
     Recruiting and education ............................................       14,232         1,980        26,052        16,235
     Office expense and other ............................................       19,815        17,712        50,217        53,076
     Rent ................................................................        3,410         3,470         8,741         7,420
     Interest ............................................................        1,350            --         4,050            --
     Depreciation and amortization .......................................        1,459         2,095         2,969         6,224
                                                                              ---------     ---------     ---------     ---------
                       Total expenses ....................................      150,322        98,905       380,485       321,573
                                                                              ---------     ---------     ---------     ---------
Operating income (loss) ..................................................      (15,521)      (43,240)       19,656       (22,438)
Interest income ..........................................................        2,162           650         4,760         1,840
                                                                              ---------     ---------     ---------     ---------
Income (loss) before cumulative effect of a change
     in accounting principle .............................................      (13,359)      (42,590)       24,416      (120,598)
Cumulative effect of a change in accounting
     principle ...........................................................           --            --       (82,711)           --
                                                                              ---------     ---------     ---------     ---------
Net loss .................................................................    $ (13,359)    $ (42,590)    $ (58,295)    $(120,598)
                                                                              =========     =========     =========     =========


Income (loss) per basic common share:
     Income (loss) before cumulative effect of a
        change in accounting principle ...................................    $    (.02)    $    (.07)    $     .03     $    (.20)
     Cumulative effect of a change in accounting
        Principle ........................................................           --            --          (.11)           --
                                                                              ---------     ---------     ---------     ---------
     Net loss ............................................................    $    (.02)    $    (.07)    $    (.08)    $    (.20)
                                                                              =========     =========     =========     =========
Basic average common shares outstanding ..................................      773,000       622,333       752,111       609,222
                                                                              =========     =========     =========     =========
</TABLE>


          See accompanying notes to consolidated financial statements.

                                       3
<PAGE>


                     ATLANTIC INTEGRATED HEALTH INCORPORATED

                      Consolidated Statements of Cash Flows
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                                                  Nine Months Ended
                                                                                    September 30,
                                                                                 1999          1998
                                                                               ---------     ---------
<S>                                                                            <C>           <C>
Cash flows from operating activities:
Net loss ..................................................................    $ (58,295)    $(120,598)
Adjustments to reconcile net loss to net cash used in operating activities:
              Depreciation and amortization ...............................        2,969         6,225
              Cumulative effect of a change in accounting principle .......       82,711            --
              Increase in accounts receivable .............................      (63,676)      (32,584)
              (Increase)/Decrease in prepaid expenses .....................       (1,491)          928
              Increase in accrued interest payable ........................        4,050            --
              Increase in accounts payable ................................       13,903        10,919
                                                                               ---------     ---------
                       Net cash used in operating activities ..............      (19,829)     (135,110)
                                                                               ---------     ---------

Cash flows from investing activities:
     Purchase of office equipment .........................................      (10,132)       (1,240)
     Purchase of investment, net of cash acquired .........................           --        20,834
                                                                               ---------     ---------
                       Net cash (used in) provided by investing activities       (10,132)       19,594
                                                                               ---------     ---------

Cash flows provided by financing activities:
     Proceeds from issuance of common stock ...............................      117,550        80,235
                                                                               ---------     ---------
                       Net cash provided by financing activities ..........      117,550        80,235
                                                                               ---------     ---------

Net increase(decrease) in cash ............................................       87,589       (35,281)
Cash, beginning of period .................................................      115,507       101,776
                                                                               ---------     ---------
Cash, end of period .......................................................    $ 203,096     $  66,495
                                                                               =========     =========
Supplemental disclosure:
     Common stock issued in exchange for note .............................    $  20,550     $  18,235
     Acquisition of The Beacon Company:
         Fair market value of development costs acquired ..................           --        70,166
         Assumption of subordinated convertible debenture .................           --        90,000
                                                                               =========     =========
</TABLE>


          See accompanying notes to consolidated financial statements.

                                       4
<PAGE>


                     ATLANTIC INTEGRATED HEALTH INCORPORATED

                                   FORM 10-QSB
                               SEPTEMBER 30, 1999

             Notes to Consolidated Financial Statements (Unaudited)

1.          INTERIM FINANCIAL INFORMATION

            In the opinion of management, the accompanying unaudited
consolidated financial statements contain all necessary adjustments, which are
of a normal recurring nature, to present fairly the financial position of
Atlantic Integrated Health Incorporated and its wholly-owned subsidiary, The
Beacon Company, as of September 30, 1999 and 1998, the results of operations for
the three months and nine months ended September 30, 1999 and 1998, and the cash
flows for the nine months ended September 30, 1999 and 1998, in conformity with
generally accepted accounting principles. Operating results for the nine-month
period ended September 30, 1999 are not necessarily indicative of the results
that may be expected for the year ended December 31, 1999.

            These unaudited interim consolidated financial statements should be
read in conjunction with the financial statements and related notes contained in
the Company's Annual Report on Form 10-KSB dated December 31, 1998.

2.          INVESTMENT

            The Company, in conjunction with Kanawha Insurance Company
("Kanawha"), formed Beacon in January 1997 when each contributed $1,000 of
capital for an equal number of shares. Beacon plans to market and sell health
care services and related employee benefit products, primarily in eastern North
Carolina. The Company accounted for its investment on the equity method.

            On June 24, 1998, the Company purchased all of the shares of common
stock of Beacon held by Kanawha in exchange for $1,000 cash and the issuance by
Beacon of a convertible, subordinated debenture in the principal amount of
$90,000 (the "Debenture"). The Debenture is due and payable on June 30, 2003 and
bears interest at the rate of 6% per annum. The Debenture is convertible into 4%
of Beacon's outstanding common stock if Beacon completes a public offering of
its common stock. Beacon does not have any right to redeem the Debenture prior
to maturity. Upon the occurrence of an "Event of Default," as defined under the
Debenture, the entire unpaid principal and accrued interest will become
immediately due and payable.

            As a result of this transaction, Beacon has been consolidated with
the Company as of June 30, 1999 and for all accounting periods from June 24,
1998 through September 30, 1999.

3.          NET INCOME (LOSS) PER SHARE

            Net income (loss) per share is computed by dividing the net income
(loss) for the period by the weighted average number of shares of common stock
outstanding during the period.

4.          EXTENSION OF STOCK OFFERING

            On June 22, 1999, the Company filed a Post-Effective Amendment No. 5
to its Registration Statement on Form SB-2 to extend its stock offering, which
terminated on March 10, 1999. The Securities and Exchange Commission declared
the Post-Effective Amendment No. 5 effective on July 13, 1999.

                                       5
<PAGE>


5.          NEWLY ISSUED ACCOUNTING STANDARD

            In April 1998, the American Institute of Certified Public
Accountants issued Statement of Position No. 98-5 "Reporting on the Costs of
Start-Up Activities" (SOP 98-5) which provides guidance on the financial
reporting of start-up costs and organization costs and requires that all
non-governmental entities expense the costs of start-up activities as these
costs are incurred instead of being capitalized and amortized. Atlantic adopted
SOP 98-5 on January 1, 1999. The initial impact of adopting SOP 98-5 resulted in
a charge of $82,711, which has been reflected as a cumulative effect of a change
in accounting principle in the accompanying consolidated statement of operations
for the nine months ended September 30, 1999.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATION

            THIS FORM 10-QSB CONTAINS CERTAIN FORWARD-LOOKING STATEMENTS. FOR
THIS PURPOSE, ANY STATEMENTS CONTAINED IN THIS FORM 10-QSB THAT ARE NOT
STATEMENTS OF HISTORICAL FACT MAY BE DEEMED TO BE FORWARD-LOOKING STATEMENTS.
WITHOUT LIMITING THE FOREGOING, WORDS SUCH AS "MAY," "WILL," "EXPECT," BELIEVE,"
"ANTICIPATE," "ESTIMATE" OR "CONTINUE" OR THE NEGATIVE OR OTHER VARIATIONS
THEREOF OR COMPARABLE TERMINOLOGY ARE INTENDED TO IDENTIFY FORWARD-LOOKING
STATEMENTS. THESE STATEMENTS BY THEIR NATURE INVOLVE SUBSTANTIAL RISKS AND
UNCERTAINTIES, AND ACTUAL RESULTS MAY DIFFER MATERIALLY DEPENDING ON A VARIETY
OF FACTORS, INCLUDING THOSE DESCRIBED UNDER THE CAPTION "RISK FACTORS" CONTAINED
IN THE COMPANY'S ANNUAL REPORT ON FORM 10-KSB FOR THE FISCAL YEAR ENDED DECEMBER
31, 1998.

            The following discussion of the results of the operations and
financial condition of Atlantic should be read in conjunction with Atlantic's
Consolidated Financial Statements and the related notes thereto.

OVERVIEW

            We are an independent, physician-owned and governed, integrated
medical practice group network. Since our inception, we have focused our efforts
on providing administrative services to participating physicians and medical
practice groups and on developing a community-based, integrated health care
delivery system to provide quality, cost-effective health care to the citizens
of eastern North Carolina. We are in the process of integrating, economically
and clinically, physicians practicing primarily in single-specialty medical
practice groups into a larger multi-specialty network of physicians and medical
practice groups. Physicians participating in our network provide primary and
referral specialty heath care services to managed care health plan enrollees and
other patients. We continue to develop strategic alliances with payors of health
care services and other health care providers to achieve greater coordination of
the delivery of and payment of health care services.

            As of November 10, 1999, we had entered into medical services
provider agreements covering over 500 physicians located in 22 counties in
eastern North Carolina. Additionally, as of November 10, 1999, through our
subsidiary, The Beacon Company, we had entered into facility participation
agreements with eight hospitals in eastern North Carolina.

            We derive our revenues from four main sources:

            *           fees paid by employers, managed care health plans, and
                        other third-party payors to access our integrated
                        provider network;

            *           commissions and fees paid by employers for health plan
                        related administrative and consulting services;

                                       6
<PAGE>


            *           fees paid by vendors on behalf of participating
                        physicians for providing group purchasing and related
                        services; and

            *           administrative service fees paid by participating
                        physicians.

RESULTS OF OPERATIONS

THREE MONTHS ENDED SEPTEMBER 30, 1999 COMPARED TO THREE MONTHS ENDED SEPTEMBER
30, 1998

            Revenue increased from $55,665 for the three months ended September
30, 1998 to $134,801 for the three months ended September 30, 1999, an increase
of $79,136, or 142%. This increase was due to a strong growth in group
purchasing contract revenue and network access fees.

            Operating expenses increased from $98,905 for the three months ended
September 30, 1998 to $150,322 for the three months ended September 30, 1999.
This increase was attributable to the addition of new staff and related
recruiting and sales expenses.

            Salaries and wages increased from $57,160 for the three months ended
September 30, 1998 to $108,110 for the three months ended September 30, 1999, an
increase of $50,950. This increase was due to higher salaries and a larger
number of employees. Recruiting and education increased from $1,980 for the
three months ended September 30, 1998 to $14,232 for the three months ended
September 30, 1999, an increase of $12,232. This increase was related to the
growth in the network and enhanced sales and marketing efforts. Office and other
expenses increased from $17,712 in the three months ended September 30, 1998 to
$19,815 in the three months ended September 30, 1999, an increase of $2,103.
Consulting fees decreased from $16,488 for the three months ended September 30,
1998 to $1,946 for the three months ended September 30, 1999, a decrease of
$14,542. This decrease was attributed to the completion of several consulting
projects that were active during 1998.

            The net loss for Atlantic decreased from $42,590 for the three
months ended September 30, 1998 to $13,359 for the three months ended September
30, 1999. The reduction in losses resulted from strong revenue growth in excess
of growth in expenses. While Atlantic's revenue exceeded management's
expectations during the third quarter of 1999, management anticipates continued
operating losses as it continues to expand its operations.

NINE MONTHS ENDED SEPTEMBER 30, 1999 COMPARED TO NINE MONTHS ENDED SEPTEMBER 30,
1998

            Revenue increased from $199,135 for the nine months ended September
30, 1998 to $400,141 for the nine months ended September 30, 1999, an increase
of $201,006, or 101%. This increase was due to a strong growth in group
purchasing contract revenue and network access fees.

            Salaries and wages increased from $214,733 for the nine months ended
September 30, 1998 to $267,036 for the nine months ended September 30, 1999, an
increase of $52,303. This increase was due to the addition of new employees and
the replacement of existing employees at higher salaries. These personnel
changes took place near the end of the second quarter of 1999. Recruiting and
education increased from $16,235 for the nine months ended September 30, 1998 to
$26,052 for the nine months ended September 30, 1999, an increase of $9,817.
This increase was related to the growth in the network and enhanced sales and
marketing efforts. Office and other expenses decreased from $53,076 in the nine
months ended September 30, 1998 to $50,217 in the nine months ended September
30, 1999, a decrease of $2,859. This decrease was attributable to temporary
decreases in fees paid to credential the physician network and printing provider
directories. Consulting fees decreased slightly from $23,885 for the nine months
ended September 30, 1998 to $21,420 for the nine months ended September 30,
1999, a decrease of $2,465.

                                       7
<PAGE>


            The operating income for Atlantic before the cumulative effect of
change in accounting principle was $19,656 for the nine months ended September
30, 1999 compared to an operating loss of $122,438 for the nine months ended
September 30, 1998. The operating income for the nine months ended September 30,
1999 primarily resulted from an increase in revenues in advance of the hiring of
new personnel. Atlantic incurred a net loss after the cumulative effect of a
change in accounting principle of $58,295 in the nine months ended September 30,
1999 compared with a net loss of $120,598 in the nine months ended September 30,
1998. The net loss primarily resulted from the adoption by Atlantic of the
provisions of Statement of Position No. 98-5, "Reporting on the Costs of
Start-Up Activities" (SOP 98-5) at the beginning of the first quarter of 1999.
SOP 98-5 provides guidance on the financial reporting of start-up costs and
organization costs and requires that all non-governmental entities expense the
costs of start-up activities as these costs are incurred instead of being
capitalized and amortized. The initial impact of adopting SOP 98-5 resulted in a
charge of $82,711. While Atlantic's operating income before the cumulative
effect of adopting SOP 98-5 exceeded management's expectations during the first
nine months of 1999, management anticipates continued operating losses.

LIQUIDITY AND CAPITAL RESOURCES

            To date, Atlantic has financed its operations through the sale of
equity securities and the collection of administrative fees combined with
revenue from ongoing operations.

            On October 19, 1996, Atlantic filed a Registration Statement on Form
SB-2 with the Commission, pursuant to which Atlantic registered for offer and
sale under the federal securities laws (i) 700,000 Primary Class Common Shares;
(ii) 1,400,000 Referral Class Common Shares; and (iii) 150,000 Nonprofit Class
Nonvoting Common Shares. The Commission declared Atlantic's Registration
Statement effective on December 30, 1996, and certain officers and directors of
Atlantic commenced sale of Atlantic's shares shortly thereafter. During the
initial offering period which closed on July 28, 1997, Atlantic sold 116,000
Primary Class Common Shares, 216,000 Referral Class Common Shares and no
Nonprofit Class Nonvoting Common Shares. On September 22, 1997, Atlantic filed a
Post-Effective Amendment No. 2 to the Registration Statement. The Commission
declared the Post-Effective Amendment No. 2 effective on September 30, 1997.
During the second offering period which closed on April 28, 1998, Atlantic sold
an aggregate of 26,000 Primary Class Common Shares, 76,000 Referral Class Common
Shares and no Nonprofit Class Nonvoting Common Shares. On June 24, 1998,
Atlantic filed a Post-Effective Amendment No. 3 and on August 7, 1998 a
Post-Effective Amendment No. 4 in response to the Commission's comments on
Post-Effective Amendment No. 3. The Commission declared the Post-Effective
Amendment No. 4 effective on August 12, 1998. During the third offering period
which closed on March 10, 1999, Atlantic sold an aggregate of 14,000 Primary
Class Common Shares, 136,000 Referral Class Common Shares and 2,000 Nonprofit
Class Nonvoting Common Shares. Atlantic sold an aggregate of 156,000 Primary
Class Common Shares, 428,000 Referral Class Common Shares and 2,000 Nonprofit
Class Nonvoting Common Shares since the Registration Statement was first
declared effective on December 30, 1996. On June 22, 1999, Atlantic filed
Post-Effective Amendment No. 5. The Commission declared the Post-Effective
Amendment No. 5 effective on July 13, 1999. Since July 13, 1999, Atlantic has
sold an aggregate of 4,000 Primary Class Common Shares, 2,000 Referral Class
Common Shares and no Nonprofit Class Nonvoting Common Shares. The net proceeds
from Atlantic's Offering have been used for working capital.

            Atlantic had $277,091 and $98,273 in working capital at September
30, 1999 and 1998, respectively. Atlantic's cash was $203,096 and $66,495 at
September 30, 1999 and 1998, respectively. The increase in Atlantic's working
capital and cash balance is due to the increase in revenues described above and
Atlantic's stock offering. Depending upon the success of Atlantic's stock
offering and the amount of future revenue earned, Atlantic believes that
sufficient liquidity is available to satisfy its working capital through
December 31, 2000. In the event that the Company's future stock sales and
revenues derived from network development and access fees are lower than
projected, the Company anticipates that it may charge its shareholders
assessments, reduce the number of its employees or decrease compensation paid to
its officers.

                                       8
<PAGE>


            Atlantic did not have any material commitments for capital
expenditures as of September 30, 1999.

                                       9
<PAGE>


                           PART II - OTHER INFORMATION

ITEM 1 - LEGAL PROCEEDINGS

            None.

ITEM 2 - CHANGES IN SECURITIES AND USE OF PROCEEDS

            During the three months ended September 30, 1999, the Company has
not issued or sold any securities that were not registered under the Securities
Act of 1933, as amended.

            On October 19, 1996, Atlantic filed a Registration Statement on Form
SB-2 with the Commission, pursuant to which Atlantic registered for offer and
sale under the federal securities laws (i) 700,000 Primary Class Common Shares;
(ii) 1,400,000 Referral Class Common Shares; and (iii) 150,000 Nonprofit Class
Nonvoting Common Shares. The Commission declared Atlantic's Registration
Statement effective on December 30, 1996, and certain officers and directors of
Atlantic commenced sale of Atlantic's shares shortly thereafter. During the
initial offering period which closed on July 28, 1997, Atlantic sold 116,000
Primary Class Common Shares, 216,000 Referral Class Common Shares and no
Nonprofit Class Nonvoting Common Shares. On September 22, 1997, Atlantic filed a
Post-Effective Amendment No. 2 to the Registration Statement. The Commission
declared the Post-Effective Amendment No. 2 effective on September 30, 1997.
During the second offering period which closed on April 28, 1998, Atlantic sold
an aggregate of 26,000 Primary Class Common Shares, 76,000 Referral Class Common
Shares and no Nonprofit Class Nonvoting Common Shares. On June 24, 1998,
Atlantic filed a Post-Effective Amendment No. 3 and on August 7, 1998 a
Post-Effective Amendment No. 4 in response to the Commission's comments on
Post-Effective Amendment No. 3. The Commission declared the Post-Effective
Amendment No. 4 effective on August 12, 1998. During the third offering period
which closed on March 10, 1999, Atlantic sold an aggregate of 14,000 Primary
Class Common Shares, 136,000 Referral Class Common Shares and 2,000 Nonprofit
Class Nonvoting Common Shares. Atlantic sold an aggregate of 156,000 Primary
Class Common Shares, 428,000 Referral Class Common Shares and 2,000 Nonprofit
Class Nonvoting Common Shares since the Registration Statement was first
declared effective on December 30, 1996. On June 22, 1999, Atlantic filed
Post-Effective Amendment No. 5. The Commission declared the Post-Effective
Amendment No. 5 effective on July 13, 1999. Since July 13, 1999, Atlantic has
sold an aggregate of 4,000 Primary Class Common Shares, 2,000 Referral Class
Common Shares and no Nonprofit Class Nonvoting Common Shares.

            Since the Registration Statement was first declared effective on
December 30, 1996, the Company has received $592,000 in gross proceeds, $110,000
of which the Company estimates has been used for offering expenses and the
balance of which has been used for working capital. All of the expenses incurred
in connection with the offering were paid to unrelated parties or entities. The
vast majority of the offering expenses were paid to attorneys, accountants and
financial printers. The balance of the net proceeds received by Atlantic was
used to fund general working capital purposes, including payment of rent and the
salaries of certain directors and officers.

ITEM 3 - DEFAULTS UPON SENIOR SECURITIES

            Not applicable.

ITEM 4 - SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

            None.

ITEM 5 - OTHER INFORMATION

            None.

                                       10
<PAGE>


ITEM 6 - EXHIBITS AND REPORTS ON FORM 8-K

            (a)         Exhibits.

                        Exhibit
                        Number                          Description
                        ------                          -----------

                         27.1                      Financial Data Schedule

            (b)         Reports on Form 8-K.

                        No reports on Form 8-K were filed during the quarter
                        ended September 30, 1999.



                                   SIGNATURES

            Pursuant to the requirements of the Securities and Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.

                           ATLANTIC INTEGRATED HEALTH
November 10, 1999          INCORPORATED


                           By: /s/  J. Philip Mahaney Jr., M.D.
                               -------------------------------------------------
                                    J. Philip Mahaney, Jr., M.D.
                                    President and Chief Executive Officer
                                    (principal executive officer)


                           By: /s/  Stephen W. Nuckolls
                               -------------------------------------------------
                                    Stephen W. Nuckolls
                                    Chief Financial Officer
                                    (principal financial and accounting officer)

                                       11
<PAGE>


                                  EXHIBIT INDEX


Exhibit Number             Description                       Location
--------------             -----------                       --------

    27.1             Financial Data Schedule       Filed herewith electronically

                                       12